LABORATOIRE SANDRALEX : revenue, balance sheet and financial ratios

LABORATOIRE SANDRALEX is a French company founded 26 years ago, specialized in the sector Fabrication de parfums et de produits pour la toilette. Based in PEYPIN (13124), this company of category PME shows in 2021 a revenue of 9.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRE SANDRALEX (SIREN 429644578)
Indicator 2021 2020 2019 2018 2017 2016
Revenue 9 033 337 € N/C 5 638 699 € 5 575 885 € 4 525 669 € 3 483 486 €
Net income 847 978 € 1 641 579 € 405 249 € 309 509 € 209 395 € 159 979 €
EBITDA 1 243 838 € N/C 625 046 € 479 937 € 349 462 € 285 740 €
Net margin 9.4% N/C 7.2% 5.6% 4.6% 4.6%

Revenue and income statement

In 2021, LABORATOIRE SANDRALEX achieves revenue of 9.0 M€. Over the period 2016-2021, the company shows strong growth with a CAGR (compound annual growth rate) of +21.0%. After deducting consumption (5.3 M€), gross margin stands at 3.7 M€, i.e. a rate of 41%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 1.2 M€, representing 13.8% of revenue. This level of operating margin is satisfactory for the sector. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 848 k€, i.e. 9.4% of revenue. This profit can be retained or distributed to shareholders.

Revenue (2021) ?
Revenue
Definition
Total amount of sales of goods and services made by the company.
Formula
Sales of goods + Sold production

9 033 337 €

Gross margin (2021) ?
Gross margin
Definition
Difference between revenue and cost of goods sold.
Formula
Revenue - Cost of goods consumed

3 709 578 €

EBITDA (2021) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

1 243 838 €

EBIT (2021) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

1 073 567 €

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

847 978 €

EBITDA margin (2021) ?
EBITDA margin
Definition
Measures the company's operating profitability.
Formula
(EBE / CA) x 100
Interpretation
> 10% : Good profitability
5-10% : Average
< 5% : Low

13.8%

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 27%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 58%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 1.1 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 11.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

27.301%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

57.678%

Cash flow / Revenue (2021) ?
Cash flow / Revenue
Definition
Self-financing capacity relative to revenue.
Formula
(CAF / CA) x 100
Interpretation
The higher the ratio, the more cash the company generates

11.208%

Repayment capacity (2021) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

1.052

Asset age ratio (2021) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

39.4%

Solvency indicators evolution
LABORATOIRE SANDRALEX

Sector positioning

Debt ratio
27.3 2021
2019
2020
2021
Q1: 0.0
Med: 23.13
Q3: 88.71
Average +13 pts over 3 years

In 2021, the debt ratio of LABORATOIRE SANDRALEX (27.30) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
57.68% 2021
2019
2020
2021
Q1: 15.89%
Med: 38.97%
Q3: 63.24%
Good -6 pts over 3 years

In 2021, the financial autonomy of LABORATOIRE SANDRALEX (57.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
1.05 years 2021
2019
2021
Q1: 0.0 years
Med: 0.07 years
Q3: 1.73 years
Average +12 pts over 2 years

In 2021, the repayment capacity of LABORATOIRE SANDRALEX (1.05) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 327.60. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 0.1x. Danger: operating income does not cover interest charges, unsustainable situation.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

327.601

Interest coverage (2021) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

0.11

Liquidity indicators evolution
LABORATOIRE SANDRALEX

Sector positioning

Liquidity ratio
327.6 2021
2019
2020
2021
Q1: 133.11
Med: 224.64
Q3: 387.13
Good

In 2021, the liquidity ratio of LABORATOIRE SANDRALEX (327.60) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
0.11x 2021
2019
2021
Q1: 0.0x
Med: 0.38x
Q3: 4.32x
Average +6 pts over 2 years

In 2021, the interest coverage of LABORATOIRE SANDRALEX (0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 39 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 73 days. Excellent situation: suppliers finance 34 days of the operating cycle (retail model). Inventory turnover is 53 days (= Average inventory / Cost of goods x 360). Overall, WCR represents 107 days of revenue, i.e. 2.7 M€ to permanently finance. Over 2016-2021, WCR increased by +312%, requiring additional financing.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

2 681 365 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

39 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

73 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

53 j

WCR in days of revenue (2021) ?
WCR in days of revenue
Definition
Expresses working capital requirement in days of revenue.
Formula
(Operating WCR / Revenue) x 360
Interpretation
The fewer days, the better the working capital management

107 j

WCR and payment terms evolution
LABORATOIRE SANDRALEX

Positioning of LABORATOIRE SANDRALEX in its sector

Comparison with sector Fabrication de parfums et de produits pour la toilette

Valuation estimate

Based on 74 transactions of similar company sales (all years), the value of LABORATOIRE SANDRALEX is estimated at 777 624 € (range 353 082€ - 2 292 162€). With an EBITDA of 1 243 838€, the sector multiple of 0.6x is applied. The price/revenue ratio is 0.11x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2021
74 tx
353k€ 777k€ 2292k€
777 624 € Range: 353 082€ - 2 292 162€
Section all-time Aggregated at NAF section level

Valuation detail by method

Ajustez les pondérations selon votre analyse

EBITDA Multiple 50%
1 243 838 € × 0.6x
Estimation 777 431 €
235 526€ - 1 792 780€
Revenue Multiple 30%
9 033 337 € × 0.11x
Estimation 992 260 €
647 534€ - 2 257 540€
Net Income Multiple 20%
847 978 € × 0.5x
Estimation 456 154 €
205 297€ - 3 592 553€
How is this estimate calculated?

This estimate is based on the analysis of 74 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de parfums et de produits pour la toilette)

Compare LABORATOIRE SANDRALEX with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de parfums et de produits pour la toilette

Frequently asked questions about LABORATOIRE SANDRALEX

What is the revenue of LABORATOIRE SANDRALEX ?

The revenue of LABORATOIRE SANDRALEX in 2021 is 9.0 M€.

Is LABORATOIRE SANDRALEX profitable?

Yes, LABORATOIRE SANDRALEX generated a net profit of 848 k€ in 2021.

Where is the headquarters of LABORATOIRE SANDRALEX ?

The headquarters of LABORATOIRE SANDRALEX is located in PEYPIN (13124), in the department Bouches-du-Rhone.

Where to find the tax return of LABORATOIRE SANDRALEX ?

The tax return of LABORATOIRE SANDRALEX is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRE SANDRALEX operate?

LABORATOIRE SANDRALEX operates in the sector Fabrication de parfums et de produits pour la toilette (NAF code 20.42Z). See the 'Sector positioning' section above to compare the company with its competitors.